Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.

Adjailia EB, Grasshoff H, Schinke S, Fourlakis K, Jendrek ST, Lamprecht P, Riemekasten G, Humrich JY.

Open source

DOI
10.1136/rmdopen-2025-005493
Published
2025-06-10
Container
RMD Open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2025-005493,
  title = {Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.},
  author = {Adjailia EB and  Grasshoff H and  Schinke S and  Fourlakis K and  Jendrek ST and  Lamprecht P and  Riemekasten G and  Humrich JY.},
  year = {2025},
  journal = {RMD Open},
  doi = {10.1136/rmdopen-2025-005493},
  url = {https://doi.org/10.1136/rmdopen-2025-005493}
}

RIS

TY  - JOUR
TI  - Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.
AU  - Adjailia EB
AU  -  Grasshoff H
AU  -  Schinke S
AU  -  Fourlakis K
AU  -  Jendrek ST
AU  -  Lamprecht P
AU  -  Riemekasten G
AU  -  Humrich JY.
PY  - 2025
JO  - RMD Open
DO  - 10.1136/rmdopen-2025-005493
UR  - https://doi.org/10.1136/rmdopen-2025-005493
ER  - 

APA

EB, A., H, G., S, S., K, F., ST, J., P, L., G, R., & JY., H. (2025). Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.. RMD Open. https://doi.org/10.1136/rmdopen-2025-005493

Source records